SCHEMBL4290620

SCHEMBL4290620

CC(Cc1nc2c(nc(-c3ccc(Cl)cc3)n2CC(F)F)c(=O)[nH]1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 3/20 0.45
PDE1C Q14123 1/20 0.45
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 4/20 0.36
PKM P14618 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 1/20 0.36
AVPR2 P30518 5/20 0.34
AVPR1A P37288 5/20 0.34
TRPV1 Q8NER1 1/20 0.34
DHFR P00374 1/20 0.34
KDM5A P29375 1/20 0.34
MAPT P10636 1/20 0.33
FBP1 P09467 1/20 0.33
SLC6A2 P23975 1/20 0.32
OXTR P30559 1/20 0.32
OPRK1 P41145 1/20 0.32
AVPR1B P47901 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776027 0.89 HPGD (0.35) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4296187 0.88 PDE9A (0.48) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4297801 0.88 PDE9A (0.48) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4775972 0.82 KDM4E (0.36) KDM4EALDH1A1HPGDPKMMEN1
SCHEMBL4776108 0.82 KDM4E (0.38) KDM4EALDH1A1HPGDPKMMEN1
SCHEMBL4290696 0.80 ALDH1A1 (0.38) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4292483 0.80 PDE9A (0.36) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4297747 0.79 PDE9A (0.46) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4774088 0.78 CNR1 (0.37) PDE9APDE1CKDM4EALDH1A1HPGD
SCHEMBL4295752 0.78 MEN1 (0.42) PDE9APDE1CKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061470-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES Neurogen Corporation (US) 2009-05-27 EP claimed
WO-2008024433-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2008-02-28 WO claimed
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed